Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience
In: ANTIVIRAL RESEARCH, Jg. 134 (2016), S. 58-62
serialPeriodical
Zugriff:
Titel: |
Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience
|
---|---|
Autor/in / Beteiligte Person: | El-Haddad, D. ; El Chaer, F. ; Vanichanan, J. ; Shah, D. P. ; Ariza-Heredia, E. J. ; Mulanovich, V. E. ; Gulbis, A. M. ; Shpall, E. J. ; Chemaly, R. F. |
Link: | |
Zeitschrift: | ANTIVIRAL RESEARCH, Jg. 134 (2016), S. 58-62 |
Veröffentlichung: | 2016 |
Medientyp: | serialPeriodical |
ISSN: | 0166-3542 (print) |
Sonstiges: |
|